Cargill, Precision BioSciences team up to develop next generation of low saturate, high oleic canola oil
Date:Feb. 23, 2018
Precision BioSciences, Inc. is a biotechnology company focused on developing and commercializing therapeutics and services based on its ability to enable site-specific genome modifications within a living organism. This technology, called the Directed Nuclease Editor (DNE), is a fully rational, proprietary design process that allows us to insert, remove, or modify DNA at nearly any gene in nearly any organism.
Picture